Home ETF List About

Portfolio Holdings Detail for ISIN IE00B5BMR087
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCSP1(GBX) LSE
ETF TickerSXR8(EUR) F
ETF TickerCSP1.LS(GBX) CXE
ETF TickerCSPX.AS(EUR) CXE
ETF TickerCSPX.LS(USD) CXE
ETF TickerCSSPX.MI(EUR) CXE
ETF TickerCSSPXz(USD) CXE
ETF TickerSXR8.DE(EUR) CXE
ETF TickerCSSPX(EUR) ETF Plus
ETF TickerCSPX(EUR) Euronext Amsterdam
ETF TickerCSP1.L(GBP) LSE

Holdings detail for CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

Show aggregate CRL holdings

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen
Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO
(RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Analysts Expect 10% Gains Ahead For The Holdings of SPUS
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price
In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Congress Trade: Representative Jefferson Shreve Just Disclosed New Stock Trades
Representative Jefferson Shreve just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Jefferson Shreve and other politicians. - 2025-06-23 10:13:39
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications
The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL)
Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52

iShares Core S&P 500 UCITS ETF USD (Acc) CRL holdings

DateNumber of CRL Shares HeldBase Market Value of CRL SharesLocal Market Value of CRL SharesChange in CRL Shares HeldChange in CRL Base ValueCurrent Price per CRL Share HeldPrevious Price per CRL Share Held
2025-09-26 (Friday)120,512USD 17,903,263USD 17,903,263
2025-09-25 (Thursday)120,435CRL holding increased by 98USD 17,531,723CRL holding decreased by -452642USD 17,531,72398USD -452,642 USD 145.57 USD 149.45
2025-09-24 (Wednesday)120,337CRL holding increased by 364USD 17,984,365CRL holding decreased by -850196USD 17,984,365364USD -850,196 USD 149.45 USD 156.99
2025-09-18 (Thursday)119,973CRL holding increased by 7USD 18,834,561CRL holding increased by 513353USD 18,834,5617USD 513,353 USD 156.99 USD 152.72
2025-09-17 (Wednesday)119,966CRL holding increased by 63USD 18,321,208CRL holding increased by 143913USD 18,321,20863USD 143,913 USD 152.72 USD 151.6
2025-09-16 (Tuesday)119,903CRL holding increased by 28USD 18,177,295CRL holding decreased by -72475USD 18,177,29528USD -72,475 USD 151.6 USD 152.24
2025-09-15 (Monday)119,875USD 18,249,770USD 18,249,770
2025-09-12 (Friday)119,805USD 18,316,986USD 18,316,986
2025-09-11 (Thursday)119,784USD 19,134,296USD 19,134,296
2025-09-10 (Wednesday)119,749USD 18,353,929USD 18,353,929
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRL by Blackrock for IE00B5BMR087

Show aggregate share trades of CRL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY98 145.570* 158.26
2025-09-24BUY364 149.450* 158.31
2025-09-18BUY7 156.990* 158.32
2025-09-17BUY63 152.720* 158.35
2025-09-16BUY28 151.600* 158.39
2025-09-08BUY14 162.000* 158.37
2025-09-05BUY161 163.990* 158.34
2025-08-21BUY21 154.540* 158.36
2025-08-20BUY28 159.580* 158.35
2025-08-19BUY42 158.480* 158.35
2025-07-31BUY7 169.640* 158.28
2025-07-30BUY56 176.190* 158.17
2025-07-29BUY7 178.450* 158.05
2025-07-24BUY7 177.100* 157.93
2025-07-23BUY42 167.950* 157.87
2025-07-22BUY63 163.360* 157.84
2025-07-21BUY14 149.790* 157.89
2025-07-18SELL-70 154.480* 157.91 Profit of 11,054 on sale
2025-07-17BUY7 156.700* 157.92
2025-07-16BUY28 154.940* 157.94
2025-07-15SELL-105 154.420* 157.96 Profit of 16,586 on sale
2025-07-11SELL-14 159.400* 157.95 Profit of 2,211 on sale
2025-07-10BUY56 163.660* 157.91
2025-07-09BUY56 158.970* 157.90
2025-07-08BUY42 158.390* 157.90
2025-07-07SELL-161 153.900* 157.93 Profit of 25,426 on sale
2025-07-02SELL-203 157.490* 157.94 Profit of 32,062 on sale
2025-06-30BUY119 151.730* 157.98
2025-06-27BUY63 150.010* 158.04
2025-06-25SELL-14 150.210* 158.14 Profit of 2,214 on sale
2025-06-24BUY7 148.400* 158.21
2025-06-23BUY182 147.380* 158.28
2025-06-20SELL-21 147.450* 158.36 Profit of 3,326 on sale
2025-06-18SELL-42 145.290* 158.55 Profit of 6,659 on sale
2025-06-13SELL-21 149.450* 158.77 Profit of 3,334 on sale
2025-06-12BUY21 151.890* 158.82
2025-06-11BUY28 151.110* 158.88
2025-06-06SELL-35 144.700* 159.13 Profit of 5,570 on sale
2025-06-05SELL-21 141.200* 159.27 Profit of 3,345 on sale
2025-06-04SELL-28 143.220* 159.39 Profit of 4,463 on sale
2025-06-02BUY91 135.040* 159.75
2025-05-30SELL-21 135.630* 159.94 Profit of 3,359 on sale
2025-05-29BUY7 137.700* 160.12
2025-05-28SELL-7 136.250* 160.31 Profit of 1,122 on sale
2025-05-27BUY77 138.650* 160.49
2025-05-23SELL-140 136.730* 160.88 Profit of 22,523 on sale
2025-05-22SELL-154 135.600* 161.09 Profit of 24,808 on sale
2025-05-21BUY7 134.980* 161.31
2025-05-20BUY56 143.530* 161.46
2025-05-19BUY203 141.380* 161.63
2025-05-16BUY189 140.970* 161.81
2025-05-15BUY154 138.890* 162.01
2025-05-14BUY140 138.950* 162.21
2025-05-13SELL-28 144.020* 162.37 Profit of 4,546 on sale
2025-05-12BUY7 143.080* 162.55
2025-05-09BUY21 138.790* 162.76
2025-05-08SELL-203 141.360* 162.96 Profit of 33,080 on sale
2025-05-07SELL-98 136.970* 163.19 Profit of 15,993 on sale
2025-05-06BUY245 115.410* 163.64
2025-05-02BUY21 118.460* 164.48
2025-05-01SELL-35 116.890* 164.93 Profit of 5,773 on sale
2025-04-30BUY21 118.620* 165.38
2025-04-29BUY49 117.290* 165.84
2025-04-28BUY105 115.080* 166.34
2025-04-25BUY98 114.660* 166.85
2025-04-24BUY28 115.760* 167.37
2025-04-23BUY77 109.000* 167.95
2025-04-22SELL-42 106.890* 168.58 Profit of 7,080 on sale
2025-04-17BUY14 106.050* 170.59
2025-04-16BUY28 104.250* 171.29
2025-04-15BUY140 105.920* 172.00
2025-04-11BUY462 99.750* 173.51
2025-04-09BUY56 139.070* 174.72
2025-04-08BUY147 123.610* 175.30
2025-04-07BUY168 134.070* 175.78
2025-04-04SELL-420 136.900* 176.23 Profit of 74,016 on sale
2025-04-02BUY49 149.280* 176.55
2025-03-31SELL-189 150.520* 177.23 Profit of 33,496 on sale
2025-03-28SELL-119 155.550* 177.49 Profit of 21,122 on sale
2025-03-27SELL-35 158.060* 177.73 Profit of 6,221 on sale
2025-03-26BUY63 158.250* 177.98
2025-03-25SELL-84 161.350* 178.19 Profit of 14,968 on sale
2025-03-24BUY49 166.980* 178.33
2025-03-21BUY84 167.280* 178.47
2025-03-19BUY14 173.880* 178.71
2025-03-18SELL-126 176.940* 178.73 Profit of 22,520 on sale
2025-03-17BUY133 175.010* 178.79
2025-03-14BUY119 171.040* 178.89
2025-03-13BUY588 166.930* 179.06
2025-03-12BUY280 170.590* 179.18
2025-03-11BUY112 166.630* 179.36
2025-03-07BUY64 175.920* 179.48
2025-03-06SELL-63 169.270* 179.63 Profit of 11,317 on sale
2025-03-05BUY217 167.550* 179.82
2025-03-04BUY42 164.310* 180.06
2025-03-03BUY189 163.500* 180.32
2025-02-28SELL-49 165.310* 180.57 Profit of 8,848 on sale
2025-02-27BUY7 164.880* 180.82
2025-02-26SELL-14 167.960* 181.04 Profit of 2,535 on sale
2025-02-25BUY133 167.100* 181.27
2025-02-21BUY98 163.020* 181.78
2025-02-20BUY56 162.250* 182.13
2025-02-19BUY14 165.000* 182.44
2025-02-18BUY35 154.390* 182.96
2025-02-13BUY119 153.170* 184.76
2025-02-12BUY42 154.000* 185.38
2025-02-11SELL-14 154.900* 186.00 Profit of 2,604 on sale
2025-02-07SELL-56 163.790* 187.03 Profit of 10,474 on sale
2025-02-06BUY28 166.270* 187.48
2025-02-04BUY245 163.120* 188.52
2025-02-03BUY91 161.620* 189.15
2025-01-31BUY21 164.760* 189.73
2025-01-30BUY14 165.570* 190.32
2025-01-29BUY133 161.640* 191.04
2025-01-28BUY63 163.640* 191.74
2025-01-27BUY98 165.840* 192.42
2025-01-24BUY63 164.970* 193.16
2025-01-23BUY182 166.860* 193.89
2025-01-22BUY119 168.220* 194.63
2025-01-06BUY70 189.540* 194.78
2024-12-10BUY49 197.050* 194.71
2024-12-09BUY56 201.750* 194.49
2024-12-06BUY84 191.810* 194.57
2024-12-05BUY21 191.540* 194.67
2024-12-04BUY77 199.350* 194.51
2024-12-03BUY248 199.300* 194.34
2024-12-02BUY21 201.250* 194.09
2024-11-29BUY161 199.060* 193.89
2024-11-27BUY189 199.590* 193.42
2024-11-26BUY406 197.750* 193.23
2024-11-25BUY420 201.300* 192.87
2024-11-22BUY490 195.770* 192.73
2024-11-21BUY77 194.190* 192.65
2024-11-20BUY70 187.900* 192.90
2024-11-19BUY63 186.100* 193.28
2024-11-18BUY567 187.500* 193.62
2024-11-12BUY196 215.940* 192.23
2024-11-11BUY133 220.690* 190.33
2024-11-08BUY102 215.390* 188.54
2024-11-07BUY623 210.290* 186.87
2024-11-06BUY189 214.200* 184.59
2024-11-05BUY278 188.680* 184.22
2024-11-04BUY49 182.480* 184.39
2024-11-01BUY112 180.960* 184.77
2024-10-31BUY28 178.580* 185.55
2024-10-30BUY70 181.390* 186.14
2024-10-29BUY168 184.000* 186.50
2024-10-28SELL-49 186.520* 186.49 Profit of 9,138 on sale
2024-10-25BUY84 182.120* 187.58
2024-10-24BUY56 182.730* 189.20
2024-10-23BUY70 186.630* 190.49
2024-10-22BUY182 185.940* 195.04
2024-10-21BUY196 195.040* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1998,1391131,07574.9%
2025-09-1862,9972121,43651.9%
2025-09-1792,1290727,00512.7%
2025-09-16115,39612317,67336.3%
2025-09-1566,3561151,09343.9%
2025-09-1277,5570176,81743.9%
2025-09-1187,9991204,23743.1%
2025-09-10122,6560398,56430.8%
2025-09-09125,4020471,64226.6%
2025-09-08178,3420414,72943.0%
2025-09-0576,2640192,66839.6%
2025-09-0494,7920179,53352.8%
2025-09-03139,6460216,26564.6%
2025-09-02112,81930183,91061.3%
2025-08-29105,9651,040180,20658.8%
2025-08-28183,9714248,97873.9%
2025-08-2771,8910134,03453.6%
2025-08-26109,85319166,15266.1%
2025-08-25147,16623300,78148.9%
2025-08-22251,1260414,08560.6%
2025-08-21102,1520149,37668.4%
2025-08-20152,7210215,94670.7%
2025-08-19118,8310172,88768.7%
2025-08-1893,0280164,64156.5%
2025-08-1596,5001180,16553.6%
2025-08-14147,9520251,45658.8%
2025-08-13820,20601,075,15376.3%
2025-08-12299,3220438,69968.2%
2025-08-11192,9170365,05852.8%
2025-08-0892,08966222,12841.5%
2025-08-07326,647522550,23059.4%
2025-08-06532,4347,827888,87359.9%
2025-08-05283,1486539,93852.4%
2025-08-04124,11154248,83449.9%
2025-08-01162,441300281,62257.7%
2025-07-31125,6480228,70654.9%
2025-07-30115,4870188,12161.4%
2025-07-29181,1590275,84365.7%
2025-07-28198,89649321,94161.8%
2025-07-25162,642111293,83155.4%
2025-07-24385,658456820,47247.0%
2025-07-23150,6500346,02043.5%
2025-07-22205,73626821,85325.0%
2025-07-21132,794101445,92029.8%
2025-07-1893,150207186,54249.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.